These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28680153)

  • 21. Crystal structure of hexanoyl-CoA bound to β-ketoacyl reductase FabG4 of Mycobacterium tuberculosis.
    Dutta D; Bhattacharyya S; Roychowdhury A; Biswas R; Das AK
    Biochem J; 2013 Feb; 450(1):127-39. PubMed ID: 23163771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid.
    Vilchèze C; Wang F; Arai M; Hazbón MH; Colangeli R; Kremer L; Weisbrod TR; Alland D; Sacchettini JC; Jacobs WR
    Nat Med; 2006 Sep; 12(9):1027-9. PubMed ID: 16906155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate.
    Rozwarski DA; Vilchèze C; Sugantino M; Bittman R; Sacchettini JC
    J Biol Chem; 1999 May; 274(22):15582-9. PubMed ID: 10336454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence from Raman spectroscopy that InhA, the mycobacterial enoyl reductase, modulates the conformation of the NADH cofactor to promote catalysis.
    Bell AF; Stratton CF; Zhang X; Novichenok P; Jaye AA; Nair PA; Parikh S; Rawat R; Tonge PJ
    J Am Chem Soc; 2007 May; 129(20):6425-31. PubMed ID: 17472376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An integrated computational investigation to unveil the structural impacts of mutation on the InhA structural gene of Mycobacterium tuberculosis.
    Jayaraman M; Ramadas K
    J Mol Graph Model; 2020 Dec; 101():107768. PubMed ID: 33032201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent Advances and Structural Features of Enoyl-ACP Reductase Inhibitors of Mycobacterium tuberculosis.
    Inturi B; Pujar GV; Purohit MN
    Arch Pharm (Weinheim); 2016 Nov; 349(11):817-826. PubMed ID: 27775177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An overview on crystal structures of InhA protein: Apo-form, in complex with its natural ligands and inhibitors.
    Chollet A; Maveyraud L; Lherbet C; Bernardes-Génisson V
    Eur J Med Chem; 2018 Feb; 146():318-343. PubMed ID: 29407960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Function of heterologous Mycobacterium tuberculosis InhA, a type 2 fatty acid synthase enzyme involved in extending C20 fatty acids to C60-to-C90 mycolic acids, during de novo lipoic acid synthesis in Saccharomyces cerevisiae.
    Gurvitz A; Hiltunen JK; Kastaniotis AJ
    Appl Environ Microbiol; 2008 Aug; 74(16):5078-85. PubMed ID: 18552191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An inorganic iron complex that inhibits wild-type and an isoniazid-resistant mutant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
    Oliveira JS; Sousa EH; Basso LA; Palaci M; Dietze R; Santos DS; Moreira IS
    Chem Commun (Camb); 2004 Feb; (3):312-3. PubMed ID: 14740053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based design of a novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: a computer modelling approach.
    Subba Rao G; Vijayakrishnan R; Kumar M
    Chem Biol Drug Des; 2008 Nov; 72(5):444-9. PubMed ID: 19012578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis.
    Dessen A; Quémard A; Blanchard JS; Jacobs WR; Sacchettini JC
    Science; 1995 Mar; 267(5204):1638-41. PubMed ID: 7886450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into the bonding pattern for characterizing the open and closed state of the substrate-binding loop in Mycobacterium tuberculosis InhA.
    Kumar V; Sobhia ME
    Future Med Chem; 2014 Apr; 6(6):605-16. PubMed ID: 24895891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct inhibitors of InhA are active against Mycobacterium tuberculosis.
    Manjunatha UH; S Rao SP; Kondreddi RR; Noble CG; Camacho LR; Tan BH; Ng SH; Ng PS; Ma NL; Lakshminarayana SB; Herve M; Barnes SW; Yu W; Kuhen K; Blasco F; Beer D; Walker JR; Tonge PJ; Glynne R; Smith PW; Diagana TT
    Sci Transl Med; 2015 Jan; 7(269):269ra3. PubMed ID: 25568071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides.
    He X; Alian A; Ortiz de Montellano PR
    Bioorg Med Chem; 2007 Nov; 15(21):6649-58. PubMed ID: 17723305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of the tautomeric forms of isoniazid-NAD adducts to the active site of the Mycobacterium tuberculosis enoyl-ACP reductase (InhA): a theoretical approach.
    Stigliani JL; Arnaud P; Delaine T; Bernardes-Génisson V; Meunier B; Bernadou J
    J Mol Graph Model; 2008 Nov; 27(4):536-45. PubMed ID: 18955002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NADH interactions with WT- and S94A-acyl carrier protein reductase from Mycobacterium tuberculosis: an ab initio study.
    Pantano S; Alber F; Lamba D; Carloni P
    Proteins; 2002 Apr; 47(1):62-8. PubMed ID: 11870865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissecting the role of critical residues and substrate preference of a Fatty Acyl-CoA Synthetase (FadD13) of Mycobacterium tuberculosis.
    Khare G; Gupta V; Gupta RK; Gupta R; Bhat R; Tyagi AK
    PLoS One; 2009 Dec; 4(12):e8387. PubMed ID: 20027301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of cofactor-specific, bactericidal Mycobacterium tuberculosis InhA inhibitors using DNA-encoded library technology.
    Soutter HH; Centrella P; Clark MA; Cuozzo JW; Dumelin CE; Guie MA; Habeshian S; Keefe AD; Kennedy KM; Sigel EA; Troast DM; Zhang Y; Ferguson AD; Davies G; Stead ER; Breed J; Madhavapeddi P; Read JA
    Proc Natl Acad Sci U S A; 2016 Dec; 113(49):E7880-E7889. PubMed ID: 27864515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple receptor conformers based molecular docking study of fluorine enhanced ethionamide with mycobacterium enoyl ACP reductase (InhA).
    Khan AM; Shawon J; Halim MA
    J Mol Graph Model; 2017 Oct; 77():386-398. PubMed ID: 28957755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylation of enoyl-acyl carrier protein reductase InhA impacts mycobacterial growth and survival.
    Khan S; Nagarajan SN; Parikh A; Samantaray S; Singh A; Kumar D; Roy RP; Bhatt A; Nandicoori VK
    J Biol Chem; 2010 Nov; 285(48):37860-71. PubMed ID: 20864541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.